William Blair Maintains Arcellx(ACLX.US) With Buy Rating
William Blair Sticks to Its Buy Rating for Arcellx Inc (ACLX)
Analysts Are Bullish on These Healthcare Stocks: Illumina (ILMN), Arcellx Inc (ACLX)
Barclays Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $115
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Cuts Target Price to $118
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $134
Bank of America Securities Keeps Their Buy Rating on Arcellx Inc (ACLX)
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $134
Arcellx Inc: Buy Rating Affirmed on Promising Anito-cel Therapy and Strong Financial Position
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX) and PTC Therapeutics (PTCT)
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $122
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $122
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $121
Buy Rating for Arcellx Inc. Based on Promising Efficacy and Safety of BCMA CAR-T Therapy in IMMagine-1 Study
Morgan Stanley Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $111
Truist Financial Initiates Arcellx(ACLX.US) With Buy Rating
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $111 to $122
Arcellx Is Maintained at Buy by UBS
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $133
Arcellx Price Target Maintained With a $115.00/Share by HC Wainwright & Co.